Search

Fadi S Qashqari,1 Mohammad Alfelali,2 Osamah Barasheed,3,4 Ruba Almaimani,5 Anas Alghamdi,6 Sarah S Alharbi,7 Eman Balahmar,8 Ammar S Alhothali,9 Rahaf Hashim Alsharif,10 Naif A Jalal,1 Hatim Makhdoom11 1Department of Microbiology, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia; 2Department of Family and Community Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 3Research and Innovation Center, King Abdullah Medical City, Makkah, Saudi Arabia; 4Basira Center for Health Research Training and Consulting, Makkah, Saudi Arabia; 5Health Promotion and Education Department, Faculty of Public Health and Health Informatics, Umm Al-Qura University, Makkah, Saudi Arabia; 6Faculty of Dental Medicine, Umm Al-Qura University, Makkah, Saudi Arabia; 7Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia; 8College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 9Faculty of Medicine and Surgery, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia; 10Department of Nursing, King Abdullah Medical City, Makkah, Saudi Arabia; 11Department of Laboratory Technology, College of Applied Medical Sciences, Taibah University, Medina, Saudi ArabiaCorrespondence: Fadi S Qashqari, Tel +966 553552660, Email fsqashqari@uqu.edu.saBackground: This research evaluated the most visible symptoms associated with coronavirus (COVID-19) vaccines among residents in Makkah of Saudi Arabia.Methods: A cross-sectional study was conducted in 2021 among a representative sample of residents receiving COVID-19 vaccination at King Abdullah Medical City, ‏Al Ukayshiyyah, and Umm Al-Qura University vaccination centers. A total of 805 participants selected by a census sampling method were included. Data regarding characteristics, medical history, and post-vaccination symptoms were obtained with an interview-based questionnaire.Results: The participants’ mean age was 25.20 ± 15.5 years. Of them, 61.7%

Sari T Alhoufie,1 Walaa A Mumena,2 Naif Alsharif,3 Hatim M Makhdoom,1 Yahya A Almutawif,1 Khalid O Alfarouk,4 Mohammed Z Alharbi,3 Khaled Aljabri,3 Alanoud Aljifri5 1Medical Laboratories Technology Department, College of Applied Medical Sciences, Taibah University, Al-Madinah Al-Munwarah, Saudi Arabia; 2Department of Clinical Nutrition, College of Applied Medical Sciences, Taibah University, Al-Madinah Al-Munwarah, Saudi Arabia; 3King Salman Medical City, Al-Madinah General Hospital, Al-Madinah Al-Munwarah, Saudi Arabia; 4Zamzam University College, Khartoum, Sudan; 5Al-Madinah Health Cluster, Ministry of Health, Al-Madinah Al-Munwarah, Saudi ArabiaCorrespondence: Sari T Alhoufie, Medical Laboratories Technology Department, College of Applied Medical Sciences, Taibah University, Al-Madinah Al-Munwarah, Saudi Arabia, Email shoufie@taibahu.edu.saIntroduction: The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) increased the demand for intensive care unit (ICU) services. Mortality and morbidity rates among ICU COVID-19 patients are affected by several factors, such as severity, comorbidities, and coinfections. In this study, we describe the demographic characteristics of COVID-19 patients admitted to an ICU in Saudi Arabia, and we determined the predictors for mortality and prolonged ICU length of stay. Additionally, we determined the prevalence of bacterial coinfection and its effect on the outcomes for ICU COVID-19 patients.Methods: We retrospectively studied the medical records of 142 COVID-19 patients admitted to the ICU at a tertiary hospital in Madinah, Saudi Arabia. Data on demographics, medical history, mortality, length of stay, and presence of coinfection were collected for each patient.Results: Neutrophil-to-Lymphocyte ratio (NLR) and intubation were reliable predictors of mortality and ICU length of stay among these ICU COVID-19 patients. Moreover, bacterial coinfections were detected in 23.2% of the patients

Sari T Alhoufie,1 Nadir A Ibrahim,1 Areej A Alhhazmi,1 Hatim M Makhdoom,1 Hamza M Ali,1 Hassan A Hemeg,1 Yahya A Almutawif,1 Waleed H Mahallawi,1 Khalid O Alfarouk2,3 1Medical Laboratories Technology Department, College of Applied Medical Sciences, Taibah University, Al- Madinah Al-Munwarah, Saudi Arabia; 2Zamzam Research Center, Zamzam Medical College, Khartoum, Sudan; 3Alfarouk Biomedical Research LLC, Temple Terrace, FL, 33617, USACorrespondence: Sari T Alhoufie, Medical Laboratories Technology Department, College of Applied Medical Sciences, Taibah University, Al- Madinah Al-Munwarah, Saudi Arabia, Email shoufie@taibahu.edu.saBackground: Helicobacter pylori (H. pylori) infection is relevant to several chronic human diseases, from digestive diseases to renal, metabolic, and cancer diseases. H. pylori infections and chronic kidney diseases are in increasing, global records; if not well controlled in a specific population, these diseases might lead to more clinical complications.Methods: In this retrospective study, we investigated the prevalence of acute H. pylori infections among 127 dialysis patients via subjecting their serums to the enzyme-linked immunosorbent assay (ELISA) to detect the human Immunoglobulin M (IgM) against H. pylori infections. Samples were from dialysis patients in a single hemodialysis center in Medina, Saudi Arabia, from January to August 2021.Results: Our results indicated the significant prevalence of H. pylori acute infections among 33.1% of renal failure patients recruited in this study, chi-squared: 14.559, p-value: 0.0001. In addition, no significant occurrence of acute H. pylori infection among males and females, chi-squared: 1.823, p-value: 0.177. Furthermore, the prevalence of acute H. pylori infection was not significant in different age groups of renal failure patients. Chi-squared: 6.803, p-value: 0.147, despite H. pylori-infected cases predominantly represented in patients above 51 years. Moreover, we noticed that hypertension